DeepChek® Assay RT Genotyping and Drug Resistance

Name: DeepChek Assay RT Genotyping and Drug Resistance
Brand: DeepChek

A research-use HBV reverse-transcriptase genotyping assay aligned to sequencing-based drug-resistance workflows.

HBV Genotyping & Drug Resistance

HBV RT Genotyping

RUO

This assay supports amplification of relevant HBV reverse-transcriptase gene regions from DNA extracted from plasma or serum. It is positioned for laboratories working with Sanger or NGS sequencing workflows.

HBVRT geneSanger or NGSDeepChek HBV

DeepChek Assay RT Genotyping and Drug Resistance

Key Details

Targets HBV reverse-transcriptase gene regions used in genotyping and drug-resistance review.
Designed around input DNA extracted from plasma or serum specimens.
Compatible with Sanger and next-generation sequencing workflow paths.
Pairs with DeepChek HBV software/module support for downstream interpretation.

Workflow Snapshot

Target regionHBV reverse transcriptase gene

Sample inputExtracted DNA from plasma or serum

WorkflowPCR amplification plus sequencing

Software supportDeepChek HBV Software / Module

Ordering Information

Product References

Product	Reference
DeepChek Assay RT Genotyping and Drug Resistance (RUO)	113A24
DeepChek HBV Software / Module (CE-IVD)	S12-023 (BL) / S12-023 (BM)

Implementation Note

Use this assay when HBV reverse-transcriptase region coverage is the primary requirement for a sequencing-based resistance workflow.

Back To HBV Portfolio

Related HBV Assays

View HBV Portfolio